Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program

This publication has 75 references indexed in Scilit:

• Prevention of Inflammation-Induced Endothelial Dysfunction
  Circulation, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen
  Gut, 2001
• Indobufen
  Drugs & Aging, 2001
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid Arteries
  European Journal of Vascular and Endovascular Surgery, 2000
• Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
  The American Journal of Pathology, 1999
• Nonsteroidal anti-inflammatory drugs after acute myocardial infarction
  The American Journal of Cardiology, 1999
• The mortality of rheumatoid arthritis
  Arthritis & Rheumatism, 1994
• Clinical pharmacology of platelet cyclooxygenase inhibition.
  Circulation, 1985